| |
| |
|
| Insider
Information: |
Muehl Daniel W |
| Relationship: |
See Remarks |
| City: |
North Billerca |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
114,830 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,669,672 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
114,830 |
|
|
| Total
Value |
$1,669,672 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
26
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
23
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -1,216.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Repligen Corp |
RGEN |
CFO |
2006-01-19 |
10,000 |
2006-01-19 |
0 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
104,830 |
2017-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGEN |
Repligen Corp |
officerTitle |
• – – |
2006-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2017-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2017-08-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,188 |
3,038 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2017-11-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
2,875 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
3,163 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
4,779 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
4,500 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
468 |
4,720 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-08-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
5,059 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
469 |
5,286 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-11-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
546 |
5,620 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-12-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
469 |
5,852 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
6,211 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,719 |
8,427 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-05-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
7,914 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-06-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,030 |
8,467 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-08-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
8,767 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,032 |
9,335 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,031 |
10,188 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,497 |
27,388 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
22,506 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,032 |
23,043 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,623 |
27,401 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
26,741 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,030 |
27,310 |
0 |
- |
|
90 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
